Cyclic and linear bradykinin analogues: implications for B2antagonist design
- 1 July 1999
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 54 (1) , 23-31
- https://doi.org/10.1034/j.1399-3011.1999.00074.x
Abstract
Bradykinin (BK, Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) antagonists are potentially useful for treating inflammation, pain and severe trauma. To identify what chemical features might promote effective antagonism, we replaced Arg1 and Pro7 with structurally constrained and proteolytic-resistant residues, such as Bip (biphenylalanine), Dip (diphenylalanine) or 2Ind (indane amino acid). To determine which BK folding might lead to favourable interactions with receptors, the effects of cyclo(3,8) vs. cyclo(5,8) analogues were compared. The resulting BK analogues were examined for their agonistic and antagonistic activities in guinea pig ileum, rat uterus and depressor assays. The results suggest that co-planarity of the residue-7 side chain with its backbone NH is important for potent agonism as well as antagonism, and a D-directed side chain is crucial for antagonism. For residue-1 an L-orientation is important, and Dip1 may mimic a folded Arg1 side chain to elicit agonistic activities, with Bip1 mimicking an extended Arg1 side chain to elicit inhibitory activities. However, ileal and uterine receptors appear to prefer differently folded BK. For ileum, a BK conformation in which residues-3 and -8 are proximal to each other, but apart from residue-5, led to improved pA2.Keywords
This publication has 48 references indexed in Scilit:
- Side reactions in solid‐phase peptide synthesis and their applicationsInternational Journal of Peptide and Protein Research, 1996
- An NMR, CD, Molecular Dynamics, and Fluorometric Study of the Conformation of the Bradykinin Antagonist B-9340 in Water and in Aqueous Micellar SolutionsJournal of Medicinal Chemistry, 1996
- Molecular Cloning and Functional Characterization of a Mouse Bradykinin B1 Receptor GeneBiochemical and Biophysical Research Communications, 1996
- New cyclic bradykinin antagonists containing disulfide and lactam bridges at the N‐terminal sequence*International Journal of Peptide and Protein Research, 1995
- Design of potent, cyclic peptide bradykinin receptor antagonists from conformationally constrained linear peptidesJournal of Medicinal Chemistry, 1993
- Biochemical and Molecular Pharmacology of Kinin ReceptorsAnnual Review of Pharmacology and Toxicology, 1992
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Interrelationship between the kallikrein-kinin system and hypertension: A reviewGeneral Pharmacology: The Vascular System, 1988
- The cellular physiology of glandular kallikreinKidney International, 1986
- CYCLIC ANALOGUE OF BRADYKININ POSSESSING SELECTIVE AND PROLONGED BIOLOGICAL ACTIVITYInternational Journal of Peptide and Protein Research, 1981